Conferences

Conferences
American Association for Cancer Research Annual Meeting (2019)
Predictive Models for Tumor Cell Targeting with Plinabulin, Derived from In Vitro Screening and Affymetrix mRNA Expression Data

American Society of Clinical Oncology (ASCO) Annual Meeting (2019)
A Phase II trial with the Combination of Plinabulin (Plin) Pegfilgrastim(Peg): Evaluation of the Reversal of Peg’s Immune-Suppressive Potential by the Addition of Plinto Peg

American Society of Hematology (ASH) Annual Meeting (2018)
Plinabulin, a Novel Small Molecule in Development for Chemotherapy-Induced-Neutropenia (CIN) Prevention, Mobilizes CD34+ Cells through a Mechanism of Action Different from G-CSF and from CXCR4 Inhibition

Society for Immunotherapy of Cancer (SITC) Annual Meeting (2018)
Pegfilgrastim, but not Plinabulin, Generates a Blood Myeloid Cell (BMC) Repertoire with a Predominant Immunosuppressive Phenotype

European Society for Medical Oncology (ESMO) Congress (2018)
Plinabulin (Plin), a Novel non-G-CSF Molecule for the Prevention of Chemotherapy-Induced Neutropenia (CIN), has the Potential to Positively Impact Tumor Micro Environment

Society for Leukocyte Biology and International Endotoxin and Innate Immunity Society (2018)
Plinabulin-Associated Neutrophil Demargination: Evidence for a Clinically Relevant Mechanism of Action for the Prevention of Chemotherapy-Induced-Neutropenia

International Association for the Study of Lung Cancer (IASLC) 19th World Conference on Lung Cancer (2018)
Plinabulin, a Novel Immuno-Oncology Agent mitigates Docetaxel Chemotherapy – Induced-Neutropenia and -Thrombocytopenia in NSCLC Patients

American Society of Clinical Oncology (ASCO) Annual Meeting (2018)
Plinabulin (Plin), a small molecule with anti-cancer activity and a novel mechanism of action (MoA) in docetaxel (Tax) induced neutropenia: Phase (φ) 2 results from a head-to-head comparison with Pegfilgrastim (Peg)

American Association for Cancer Research (AACR) Annual Meeting (2018)
Plinabulin ameliorates chemotherapy-induced neutropenia: Mechanistic insights

Keystone 2017
Guanine nucleotide exchange factor-H1 signaling is critical for induction of anti-tumor immunity induced by microtubule-depolymerizing drugs

ASCO-SITC 2017
Plinabulin is a small molecule clinical stage immune-oncology agent for NSCLC

American Society of Hematology (ASH) Annual Meeting (2016)
Plinabulin, a Novel Small Molecule That Ameliorates Chemotherapy-Induced Neutropenia, Is Administered on the Same Day of Chemotherapy and Has Anticancer Efficacy

AACR TME 2016
Plinabulin: Evidence for an Immune-mediated Mechanism of Action